» Articles » PMID: 21448284

TDP-43 Potentiates Alpha-synuclein Toxicity to Dopaminergic Neurons in Transgenic Mice

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2011 Mar 31
PMID 21448284
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

TDP-43 and α-synuclein are two disease proteins involved in a wide range of neurodegenerative diseases. While TDP-43 proteinopathy is considered a pathologic hallmark of sporadic amyotrophic lateral sclerosis and frontotemporal lobe degeneration, α-synuclein is a major component of Lewy body characteristic of Parkinson's disease. Intriguingly, TDP-43 proteinopathy also coexists with Lewy body and with synucleinopathy in certain disease conditions. Here we reported the effects of TDP-43 on α-synuclein neurotoxicity in transgenic mice. Overexpression of mutant TDP-43 (M337V substitution) in mice caused early death in transgenic founders, but overexpression of normal TDP-43 only induced a moderate loss of cortical neurons in the transgenic mice at advanced ages. Interestingly, concomitant overexpression of normal TDP-43 and mutant α-synuclein caused a more severe loss of dopaminergic neurons in the double transgenic mice as compared to single-gene transgenic mice. TDP-43 potentiated α-synuclein toxicity to dopaminergic neurons in living animals. Our finding provides in vivo evidence suggesting that disease proteins such as TDP-43 and α-synuclein may play a synergistic role in disease induction in neurodegenerative diseases.

Citing Articles

Amygdala-predominant α-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer's disease.

Gawor K, Tome S, Vandenberghe R, Van Damme P, Vandenbulcke M, Otto M Brain Commun. 2024; 6(6):fcae442.

PMID: 39659977 PMC: 11631359. DOI: 10.1093/braincomms/fcae442.


Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases.

Jiang L, Zhang X, Hu H Int J Mol Sci. 2024; 25(22).

PMID: 39596445 PMC: 11594478. DOI: 10.3390/ijms252212380.


Genetic modifiers of synucleinopathies-lessons from experimental models.

Lee R, Koh T Oxf Open Neurosci. 2024; 2:kvad001.

PMID: 38596238 PMC: 10913850. DOI: 10.1093/oons/kvad001.


Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms.

Walker L, Attems J J Parkinsons Dis. 2023; 14(1):35-52.

PMID: 38143370 PMC: 10836576. DOI: 10.3233/JPD-230154.


Concomitant protein pathogenesis in Parkinson's disease and perspective mechanisms.

Han Y, He Z Front Aging Neurosci. 2023; 15:1189809.

PMID: 37181621 PMC: 10174460. DOI: 10.3389/fnagi.2023.1189809.


References
1.
Feiguin F, Godena V, Romano G, DAmbrogio A, Klima R, Baralle F . Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009; 583(10):1586-92. DOI: 10.1016/j.febslet.2009.04.019. View

2.
Sreedharan J, Blair I, Tripathi V, Hu X, Vance C, Rogelj B . TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008; 319(5870):1668-72. PMC: 7116650. DOI: 10.1126/science.1154584. View

3.
Li Y, Ray P, Rao E, Shi C, Guo W, Chen X . A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci U S A. 2010; 107(7):3169-74. PMC: 2840283. DOI: 10.1073/pnas.0913602107. View

4.
Zhou H, Huang C, Yang M, Landel C, Xia P, Liu Y . Developing tTA transgenic rats for inducible and reversible gene expression. Int J Biol Sci. 2009; 5(2):171-81. PMC: 2640494. DOI: 10.7150/ijbs.5.171. View

5.
Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S . Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A. 2007; 104(36):14501-6. PMC: 1964873. DOI: 10.1073/pnas.0704774104. View